PMID- 35527791
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2666-3546 (Electronic)
IS  - 2666-3546 (Linking)
VI  - 22
DP  - 2022 Jul
TI  - Brain and behavior in health communication: The Canadian COVID-19 Experiences 
      Project.
PG  - 100467
LID - 10.1016/j.bbih.2022.100467 [doi]
LID - 100467
AB  - BACKGROUND: Vaccine hesitancy and inconsistent mitigation behavior performance 
      have been significant challenges throughout the COVID-19 pandemic. In Canada, 
      despite relatively high vaccine availability and uptake, willingness to accept 
      booster shots and maintain mitigation behaviors in the post-acute phase of 
      COVID-19 remain uncertain. The aim of the Canadian COVID-19 Experiences Project 
      (CCEP) is threefold: 1) to identify social-cognitive and neurocognitive 
      predictors of mitigation behaviors, 2) to identify optimal communication 
      strategies to promote vaccination and mitigation behaviors, and 3) to examine 
      brain health outcomes of SARS-CoV-2 infection and examine their longevity. 
      METHODS: The CCEP is comprised of two components: a conventional population 
      survey (Study 1) and a functionally interconnected laboratory study (Study 2). 
      Study 1 will involve 6 waves of data collection. Wave 1, completed between 28 
      September and 21 October 2021, recruited 1,958 vaccine-hesitant (49.8%) and fully 
      vaccinated (50.2%) adults using quota sampling to ensure maximum statistical 
      power. Measures included a variety of social cognitive (e.g., beliefs, 
      intentions) and neurocognitive (e.g., delay discounting) measures, followed by an 
      opportunity to view and rate a set of professionally produced COVID-19 public 
      service announcement (PSA) videos for perceived efficacy. Study 2 employs the 
      same survey items and PSAs but coupled with lab-based eye tracking and functional 
      near-infrared spectroscopy (fNIRS) to directly quantify neural indicators of 
      attention capture and self-reflection in a smaller community sample. In the final 
      phase of the project, subjective impressions and neural indicators of PSA 
      efficacy will be compared and used to inform recommendations for construction of 
      COVID-19 PSAs into the post-acute phase of the pandemic. DISCUSSION: The CCEP 
      provides a framework for evaluating effective COVID-19 communication strategies 
      by levering conventional population surveys and the latest eye-tracking and brain 
      imaging metrics. The CCEP will also yield important information about the brain 
      health impacts of SARS-CoV-2 in the general population, in relation to current 
      and future virus variants as they emerge.
CI  - (c) 2022 The Authors.
FAU - Hall, Peter A
AU  - Hall PA
AD  - School of Public Health Sciences, University of Waterloo, Waterloo, Canada.
AD  - Department of Psychology, University of Waterloo, Waterloo, Canada.
AD  - Centre for Bioengineering and Biotechnology, University of Waterloo, Waterloo, 
      Canada.
FAU - Fong, Geoffrey T
AU  - Fong GT
AD  - School of Public Health Sciences, University of Waterloo, Waterloo, Canada.
AD  - Department of Psychology, University of Waterloo, Waterloo, Canada.
AD  - Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
FAU - Hitchman, Sara C
AU  - Hitchman SC
AD  - Department of Communication and Media Research, University of Zurich, Zurich, 
      Switzerland.
FAU - Quah, Anne C K
AU  - Quah ACK
AD  - Department of Psychology, University of Waterloo, Waterloo, Canada.
FAU - Agar, Thomas
AU  - Agar T
AD  - Department of Psychology, University of Waterloo, Waterloo, Canada.
FAU - Meng, Gang
AU  - Meng G
AD  - Department of Psychology, University of Waterloo, Waterloo, Canada.
FAU - Ayaz, Hasan
AU  - Ayaz H
AD  - School of Biomedical Engineering, Science and Health Systems, Drexel University, 
      USA.
AD  - Department of Psychological and Brain Sciences, College of Arts and Sciences, 
      Drexel University, Philadelphia, PA, USA.
AD  - Drexel Solutions Institute, Drexel University, Philadelphia, PA, USA.
FAU - Dore, Bruce P
AU  - Dore BP
AD  - Desautels Faculty of Management, McGill University, Montreal, Canada.
FAU - Sakib, Mohammad N
AU  - Sakib MN
AD  - School of Public Health Sciences, University of Waterloo, Waterloo, Canada.
FAU - Hudson, Anna
AU  - Hudson A
AD  - School of Public Health Sciences, University of Waterloo, Waterloo, Canada.
FAU - Boudreau, Christian
AU  - Boudreau C
AD  - Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, 
      Canada.
LA  - eng
PT  - Journal Article
DEP - 20220502
PL  - United States
TA  - Brain Behav Immun Health
JT  - Brain, behavior, & immunity - health
JID - 101759062
PMC - PMC9060711
OTO - NOTNLM
OT  - Behavior
OT  - COVID-19
OT  - Mitigation
OT  - Prevention
OT  - SARS-CoV-2
OT  - Vaccine
COIS- The authors have no competing interests.
EDAT- 2022/05/10 06:00
MHDA- 2022/05/10 06:01
PMCR- 2022/05/02
CRDT- 2022/05/09 03:47
PHST- 2022/04/28 00:00 [received]
PHST- 2022/04/28 00:00 [accepted]
PHST- 2022/05/09 03:47 [entrez]
PHST- 2022/05/10 06:00 [pubmed]
PHST- 2022/05/10 06:01 [medline]
PHST- 2022/05/02 00:00 [pmc-release]
AID - S2666-3546(22)00057-6 [pii]
AID - 100467 [pii]
AID - 10.1016/j.bbih.2022.100467 [doi]
PST - ppublish
SO  - Brain Behav Immun Health. 2022 Jul;22:100467. doi: 10.1016/j.bbih.2022.100467. 
      Epub 2022 May 2.